Romiplostim (Nplate®)
A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- not specified
- Value
- £6M
- Sector
- HEALTH
- Published
- 10 Sep 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
Geochart for 2 buyers and 1 suppliers
2 buyers
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Amgen Cambridge
Description
Supply of Romiplostim (NPlate®) to NHS Scotland.
Award Detail
| 1 | Amgen (Cambridge)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
Legal Justification
The medicine awarded to this framework agreement was protected by patent however since (LOE) Loss of Exclusivity there has been no new competition entered the market and therefore the awarded supplier is the only supplier who can currently provide this medication.
Other Information
The total value in section 11.1.7 and V.2.4 refers to the twenty-two (22) months agreement period. (SC Ref:807710)
Reference
- FTS 055459-2025